MT Pharmacy

Rybelsus 7 mg tablets contain the active ingredient semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes

The Rybelsus 3 mg tablet is an oval, white to light yellow oral prescription medicine containing the active ingredient semaglutide. It is primarily used, along with diet and exercise, to improve blood sugar control in adults with type 2 diabetes mellitus. The 3 mg dose is the starting dose and is typically not effective for blood sugar control; 

Rybelsus 14mg tablets contain semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used to improve blood sugar control in adults with type 2 diabetes, in addition to diet and exercise

The Empasmart 10 mg tablet is a prescription medication containing empagliflozin, primarily used to manage type 2 diabetes, heart failure, and chronic kidney disease. It belongs to a class of drugs known as sodium-glucose co-transporter 2 (SGLT2) inhibitors. 

The Empasmart 25 mg tablet is a prescription medication containing empagliflozin. It is primarily used to manage type 2 diabetes, and also helps treat heart failure and slow the progression of chronic kidney disease. It is an SGLT2 inhibitor that works by helping the kidneys remove excess sugar and salt from the body through urine. 

Trulicity 0.75 mg injection is a prescription, once-weekly, single-dose, pre-filled pen containing the active ingredient dulaglutide. It is a clear, colorless solution administered subcutaneously to help manage type 2 diabetes and reduce the risk of major cardiovascular events in adults. 

Dapasmart 10mg tablet is an oral anti-diabetic medication containing Dapagliflozin, used to treat type 2 diabetes by helping the kidneys remove excess glucose via urine. It improves glycemic control, assists in weight management, and supports cardiovascular and kidney health. It is often used alongside diet and exercise. 

Dapasmart 5mg Tablet is a prescription medication used to treat Type 2 diabetes by controlling blood sugar levels and improving glycemic control, often in combination with diet and exercise. Containing Dapagliflozin, it acts as an SGLT2 inhibitor to enhance the removal of excess sugar through urine. 

Empasmart 10mg tablets, manufactured by Healing Pharma, contain Empagliflozin, a Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitor used to treat Type 2 diabetes, reduce cardiovascular risk, and manage chronic kidney disease. It acts by aiding the kidneys to remove excess glucose through urine, promoting glycemic control and weight reduction. 

Empasmart 25mg tablets are an oral antidiabetic medication containing Empagliflozin, designed to treat Type 2 diabetes by lowering blood sugar levels. As an SGLT2 inhibitor, it helps the kidneys remove glucose via urine. It is usually taken once daily and may offer cardiovascular and kidney protective benefits. 

Trulicity 1.5 mg is a clear, colorless solution of the active ingredient dulaglutide contained in a disposable, pre-filled, single-use pen for subcutaneous injection. It is an anti-diabetic medication used primarily to treat Type 2 diabetes. 

Victoza (liraglutide) is a prescription prefilled injection pen containing a clear, colorless solution. It is a once-daily, non-insulin medication used to manage type 2 diabetes mellitus in adults and children (10 years and older). It also helps reduce the risk of major adverse cardiovascular events (heart attack, stroke, or death) in adults with type 2 diabetes and established cardiovascular disease.